Investor profile
Roger Kitterman
Corporate VC, Syndicate / Angel group, Venture capital & Managing Partner at Mass General Brigham, Founder at Mass Medical Angels, Senior Vice President at Mass General Brigham
Roger Kitterman works as a Managing Partner at Mass General Brigham. The firm's known portfolio counts 9 companies.
Is Roger Kitterman a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcareSaaS
- Focus
- Academic Medical CenterAcademic SpinoutsBiotechData AnalyticsDiagnosticsDigital HealthDrug DiscoveryEnterprise SaaSGenomicsLife-Science Angel GroupMedTechMedical DevicesNLPTelemedicine
Contacts
Affiliated funds' portfolios
Managing Partner at Mass General Brigham, whose known portfolio counts 9 companies
- Carta Healthcare
- Nocion Therapeutics
- Abcuro
- Rippl Care
- Affinia Therapeutics
- Predicta Biosciences
- Tuesday Health
- InStride Health
- Claris Biotherapeutics
Founder at Mass Medical Angels, whose known portfolio counts 7 companies
- Astrocyte Pharmaceuticals
- Cayuga Biotech
- Capillary Biomedical
- Entirety Biomedical
- Coviu
- Sentien Biotechnologies
- Lantos Technologies
Senior Vice President at Mass General Brigham, whose known portfolio counts 7 companies
- Carta Healthcare
- Abridge
- Lyndra Therapeutics
- Health Catalyst
- T2 Biosystems
- CodaMetrix
- CustomSurg
Investor Profile
Founders in the listed sectors AI, Healthcare and SaaS, and focus areas Academic Medical Center, Academic Spinouts, Biotech and Data Analytics fall inside that listing.
Stage-wise, the deals at Mass General Brigham cluster around Growth, Pre-Seed and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Roger Kitterman is worth approaching.
Colleagues
Gaurav Singal
Investor
Boston, United States
Elaine Goodman
Informatics leader and venture investor
Boston, United States
Rowland Pettit
Investor
Cambridge, United States
Pardiss Mehrzad
Investor
Boston, United States
Jeff Berman
Angel Investor
Boston, United States
Bryan Giudicelli
Newborn Medicine and Reproductive Health Advisory Board
Boston, United States
Michael Freni
Venture Partner
Boston, United States
Tina McKinney
HR Leader
Boston, United States
Jeffrey Chizmas
Member
Boston, United States
Carl Berke
Partner
Boston, United States
Meredith Fisher
Partner
Cambridge, United States
Julius Knowles
Partner
Cambridge, United States
Bhamini V.
Venture Associate
Boston, United States
Frequently asked questions
Who is Roger Kitterman?
Roger Kitterman is a corporate venture investor and syndicate member based in Brookline, Massachusetts, United States, listed as Managing Partner at Mass General Brigham. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Roger Kitterman personally.
What does Roger Kitterman invest in?
Listed sectors include AI, Healthcare and SaaS; listed focus areas include Academic Medical Center, Academic Spinouts, Biotech and Data Analytics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Roger Kitterman invest at?
Mass General Brigham appears in Growth, Pre-Seed and Seed rounds across its known deals, and Roger Kitterman is listed there as Managing Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Roger Kitterman listed at?
Roger Kitterman is listed as Managing Partner at Mass General Brigham. 13 other people in the database share a firm with Roger Kitterman.
How do I contact Roger Kitterman?
An email address, a phone number and a LinkedIn page are on file for Roger Kitterman. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal